Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Virginia Borges

Concepts (593)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
150
2026
2382
12.670
 Why?
Pregnancy Complications, Neoplastic
17
2026
63
3.530
 Why?
Postpartum Period
20
2026
373
2.790
 Why?
Cancer Survivors
20
2025
337
2.440
 Why?
Receptors, Estrogen
23
2026
401
2.210
 Why?
Antineoplastic Agents, Hormonal
16
2026
193
2.110
 Why?
Antineoplastic Combined Chemotherapy Protocols
21
2025
1963
1.880
 Why?
Carcinoma, Ductal, Breast
10
2023
89
1.680
 Why?
Mastectomy
17
2024
184
1.570
 Why?
Protein Kinase Inhibitors
7
2025
981
1.400
 Why?
Receptors, Progesterone
10
2026
243
1.250
 Why?
Lactation
9
2021
193
1.230
 Why?
Brain Neoplasms
11
2025
1329
1.200
 Why?
Female
169
2026
78845
1.180
 Why?
Carcinoma, Intraductal, Noninfiltrating
7
2023
61
1.100
 Why?
Neoplasm Metastasis
13
2025
688
1.050
 Why?
Breast
10
2021
156
1.000
 Why?
Adult
103
2026
40777
1.000
 Why?
Triple Negative Breast Neoplasms
7
2025
218
0.940
 Why?
Oxazoles
8
2025
48
0.940
 Why?
Pregnancy
37
2026
7202
0.910
 Why?
Antineoplastic Agents
12
2023
2214
0.910
 Why?
Trastuzumab
13
2023
118
0.880
 Why?
Humans
178
2026
145475
0.880
 Why?
Pyridines
9
2025
609
0.850
 Why?
Quinazolines
8
2025
266
0.840
 Why?
Mammary Glands, Human
7
2020
68
0.830
 Why?
Neoplasm Recurrence, Local
15
2026
1149
0.800
 Why?
Supreme Court Decisions
1
2022
12
0.740
 Why?
Mammary Glands, Animal
9
2021
128
0.700
 Why?
Carcinoma
3
2021
225
0.680
 Why?
BRCA2 Protein
5
2024
68
0.670
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2020
35
0.650
 Why?
Semaphorins
4
2025
37
0.650
 Why?
Fertility Preservation
7
2025
55
0.640
 Why?
Middle Aged
61
2026
36215
0.620
 Why?
Breast Feeding
6
2025
446
0.600
 Why?
Maternal Age
1
2020
128
0.600
 Why?
Prospective Studies
34
2026
8057
0.600
 Why?
Drug Resistance, Neoplasm
3
2022
881
0.600
 Why?
Prognosis
17
2026
4316
0.590
 Why?
Neoplasm Staging
19
2026
1471
0.580
 Why?
Antigens, CD
6
2025
558
0.580
 Why?
Chemotherapy, Adjuvant
16
2026
423
0.580
 Why?
Neoadjuvant Therapy
6
2021
465
0.580
 Why?
Estradiol
5
2019
515
0.560
 Why?
Biomarkers, Tumor
13
2026
1321
0.560
 Why?
Extracellular Vesicles
1
2020
171
0.540
 Why?
Young Adult
38
2026
14219
0.530
 Why?
Carcinoma in Situ
3
2022
44
0.530
 Why?
Parity
7
2022
111
0.520
 Why?
Lymphatic Metastasis
10
2021
331
0.510
 Why?
Neoplasms, Second Primary
3
2024
102
0.500
 Why?
Quality of Life
12
2025
3204
0.490
 Why?
Cyclooxygenase 2
5
2020
166
0.460
 Why?
Mutation
11
2025
4075
0.430
 Why?
Capecitabine
5
2023
56
0.420
 Why?
Melanoma
4
2018
759
0.420
 Why?
Aromatase Inhibitors
6
2019
78
0.410
 Why?
Skin Neoplasms
4
2013
849
0.410
 Why?
Carcinoma, Lobular
2
2012
56
0.410
 Why?
Liver Neoplasms
4
2016
776
0.410
 Why?
Mastectomy, Segmental
6
2022
107
0.410
 Why?
Combined Modality Therapy
10
2023
1266
0.400
 Why?
Puerperal Disorders
2
2014
36
0.390
 Why?
BRCA1 Protein
4
2024
82
0.380
 Why?
Disease-Free Survival
8
2026
767
0.370
 Why?
Stromal Cells
3
2013
121
0.360
 Why?
Tumor Suppressor Protein p53
2
2021
534
0.350
 Why?
Genes, BRCA2
3
2026
33
0.340
 Why?
Genes, BRCA1
3
2026
45
0.340
 Why?
Anxiety
7
2022
1118
0.340
 Why?
Neoplasms
7
2026
2906
0.340
 Why?
Resistance Training
2
2025
186
0.340
 Why?
Nevus, Pigmented
1
2011
35
0.330
 Why?
Sexual Partners
3
2022
193
0.330
 Why?
Epithelial Cells
6
2018
1131
0.330
 Why?
Neoplasm Invasiveness
6
2020
506
0.320
 Why?
Social Support
4
2025
646
0.310
 Why?
Fertility
5
2025
173
0.310
 Why?
Tamoxifen
7
2021
191
0.310
 Why?
Premenopause
6
2026
125
0.310
 Why?
Estrogens
4
2015
367
0.300
 Why?
Aged
30
2026
26153
0.300
 Why?
Cyclophosphamide
5
2020
270
0.300
 Why?
Radiosurgery
3
2021
399
0.300
 Why?
Adjuvants, Immunologic
2
2022
243
0.290
 Why?
Gene Expression Profiling
8
2020
1767
0.290
 Why?
Antibodies, Monoclonal, Humanized
7
2025
992
0.290
 Why?
Thrombophilia
1
2009
89
0.280
 Why?
Risk Factors
17
2024
10885
0.280
 Why?
T-Lymphocytes
6
2018
1996
0.280
 Why?
Patient Acceptance of Health Care
2
2025
881
0.280
 Why?
Cohort Studies
12
2025
6013
0.280
 Why?
GPI-Linked Proteins
4
2025
81
0.280
 Why?
Incidence
7
2024
2923
0.270
 Why?
Cell Line, Tumor
10
2025
3542
0.270
 Why?
Quinolines
3
2025
190
0.270
 Why?
Mice
21
2025
18329
0.270
 Why?
Animals
31
2025
38030
0.270
 Why?
Heterozygote
2
2026
313
0.270
 Why?
Gene Expression Regulation, Neoplastic
4
2021
1443
0.260
 Why?
Breast Neoplasms, Male
2
2018
29
0.260
 Why?
Doxorubicin
5
2020
401
0.260
 Why?
Follow-Up Studies
7
2026
5423
0.260
 Why?
Employment
2
2019
184
0.260
 Why?
Kaplan-Meier Estimate
4
2020
969
0.260
 Why?
Appetite
2
2025
80
0.260
 Why?
Decision Making
4
2022
977
0.250
 Why?
Lymphocytes, Tumor-Infiltrating
2
2026
153
0.250
 Why?
Maytansine
2
2018
18
0.250
 Why?
Myeloid-Derived Suppressor Cells
2
2018
76
0.250
 Why?
Estrogen Receptor alpha
3
2025
151
0.240
 Why?
Adaptation, Psychological
2
2022
716
0.230
 Why?
Time Factors
7
2020
7123
0.230
 Why?
Disease Management
3
2021
653
0.230
 Why?
Estrogen Receptor Antagonists
1
2025
4
0.230
 Why?
Reproductive History
2
2015
12
0.230
 Why?
CD8-Positive T-Lymphocytes
5
2023
919
0.220
 Why?
Ovarian Reserve
1
2025
18
0.220
 Why?
Germ-Line Mutation
1
2026
176
0.220
 Why?
Hematopoietic Stem Cell Transplantation
1
2011
699
0.220
 Why?
Primary Ovarian Insufficiency
1
2025
40
0.220
 Why?
Mammography
3
2025
166
0.220
 Why?
Macrophages
4
2018
1507
0.220
 Why?
Dimethyl Sulfoxide
1
2005
42
0.220
 Why?
Energy Intake
2
2025
512
0.220
 Why?
Cell Plasticity
1
2025
37
0.220
 Why?
Class I Phosphatidylinositol 3-Kinases
2
2022
108
0.210
 Why?
Proportional Hazards Models
2
2022
1327
0.210
 Why?
Genetic Predisposition to Disease
6
2024
2378
0.210
 Why?
Transforming Growth Factor beta1
1
2025
177
0.210
 Why?
Spectrometry, Mass, Electrospray Ionization
1
2005
174
0.210
 Why?
Adolescent
20
2024
22530
0.210
 Why?
Bupropion
1
2004
48
0.200
 Why?
Disease Progression
10
2020
2864
0.200
 Why?
Reproductive Techniques, Assisted
1
2024
47
0.200
 Why?
Lymph Nodes
3
2019
503
0.200
 Why?
Treatment Outcome
10
2026
11772
0.200
 Why?
Drug Administration Schedule
3
2018
782
0.200
 Why?
Tumor Microenvironment
7
2026
734
0.200
 Why?
Diarrhea
3
2019
193
0.190
 Why?
Immunotherapy
3
2025
666
0.190
 Why?
Cell Proliferation
5
2021
2507
0.190
 Why?
Disease Models, Animal
5
2020
4560
0.190
 Why?
Liver
3
2020
1896
0.190
 Why?
Pharmaceutical Preparations
1
2005
170
0.190
 Why?
Multiple Sclerosis
1
2008
489
0.190
 Why?
Age Factors
9
2021
3342
0.190
 Why?
Hypertension, Pregnancy-Induced
1
2023
69
0.190
 Why?
Aurora Kinase A
2
2019
61
0.180
 Why?
Women's Health
1
2024
314
0.180
 Why?
Chromatography, Liquid
1
2004
450
0.180
 Why?
Pilonidal Sinus
1
2001
4
0.180
 Why?
Antineoplastic Agents, Immunological
3
2019
198
0.180
 Why?
Genomic Instability
1
2022
67
0.180
 Why?
Condylomata Acuminata
1
2001
7
0.180
 Why?
Retrospective Studies
11
2026
17291
0.180
 Why?
Proteomics
2
2020
1188
0.170
 Why?
Drug Monitoring
2
2019
401
0.170
 Why?
Hematopoiesis
1
2022
193
0.170
 Why?
Nausea
2
2018
112
0.170
 Why?
Artificial Intelligence
1
2026
381
0.170
 Why?
Aged, 80 and over
7
2025
8333
0.170
 Why?
Genetic Testing
3
2026
480
0.170
 Why?
Piperazines
1
2023
375
0.170
 Why?
Ki-67 Antigen
2
2019
117
0.160
 Why?
Mass Spectrometry
1
2004
730
0.160
 Why?
Dyspareunia
1
2020
8
0.160
 Why?
Mice, Inbred BALB C
6
2019
1261
0.160
 Why?
Body Image
3
2020
96
0.160
 Why?
Cancer Care Facilities
1
2020
48
0.160
 Why?
Pregnancy-Associated Plasma Protein-A
1
2020
14
0.160
 Why?
Biopsy
4
2018
1082
0.160
 Why?
Ibuprofen
2
2018
87
0.160
 Why?
Risk
3
2013
919
0.150
 Why?
Neoplasm Grading
5
2021
310
0.150
 Why?
Mice, Inbred NOD
1
2021
613
0.150
 Why?
Carcinoma, Non-Small-Cell Lung
2
2021
1189
0.150
 Why?
p21-Activated Kinases
1
2019
13
0.150
 Why?
Benzodiazepines
1
2021
168
0.150
 Why?
Bone Neoplasms
2
2016
259
0.150
 Why?
Sexual Health
1
2020
68
0.150
 Why?
Fatigue
2
2018
364
0.150
 Why?
Cell Adhesion
1
2020
451
0.150
 Why?
Immunohistochemistry
8
2019
1716
0.150
 Why?
Pregnancy Outcome
4
2026
503
0.150
 Why?
Parkinson Disease
2
2015
599
0.140
 Why?
Sexual Dysfunctions, Psychological
1
2019
30
0.140
 Why?
Carcinoma, Ductal
2
2011
10
0.140
 Why?
Receptor, trkB
1
2019
39
0.140
 Why?
Germ Cells
3
2024
65
0.140
 Why?
Lymphangiogenesis
2
2018
27
0.140
 Why?
Response Evaluation Criteria in Solid Tumors
1
2018
21
0.140
 Why?
Cell Communication
1
2020
328
0.140
 Why?
Stress, Psychological
2
2025
1146
0.140
 Why?
Pyrazoles
3
2018
517
0.140
 Why?
Nuclear Receptor Subfamily 1, Group F, Member 3
1
2018
14
0.140
 Why?
Tryptophan Oxygenase
1
2018
33
0.140
 Why?
Ipilimumab
1
2018
40
0.140
 Why?
Neoplasm Proteins
2
2020
441
0.140
 Why?
Progesterone
2
2025
215
0.140
 Why?
Sexual Dysfunction, Physiological
1
2019
75
0.140
 Why?
Parenting
1
2022
319
0.130
 Why?
Brain-Derived Neurotrophic Factor
1
2019
154
0.130
 Why?
Cisplatin
1
2020
345
0.130
 Why?
Vitamin D
1
2021
403
0.130
 Why?
Area Under Curve
1
2018
331
0.130
 Why?
Cross-Sectional Studies
7
2025
5905
0.130
 Why?
United States
8
2025
16098
0.130
 Why?
Tretinoin
1
2018
125
0.130
 Why?
Receptors, Antigen, T-Cell
2
2023
673
0.130
 Why?
T-Lymphocytes, Regulatory
2
2018
409
0.130
 Why?
Immunity, Mucosal
1
2018
98
0.130
 Why?
Programmed Cell Death 1 Receptor
1
2019
265
0.130
 Why?
Patient Care Management
1
2017
56
0.130
 Why?
Tryptophan
1
2018
182
0.130
 Why?
Granulocytes
1
2017
81
0.120
 Why?
Socioeconomic Factors
5
2021
1323
0.120
 Why?
Case-Control Studies
3
2020
3623
0.120
 Why?
Global Health
1
2020
403
0.120
 Why?
Drug Delivery Systems
2
2010
381
0.120
 Why?
Carcinoma, Squamous Cell
1
2001
641
0.120
 Why?
Protein-Tyrosine Kinases
1
2019
431
0.120
 Why?
Metaplasia
1
2016
57
0.120
 Why?
Pancreatic Cyst
1
2017
50
0.120
 Why?
Cell Transformation, Neoplastic
3
2015
337
0.120
 Why?
Radiotherapy, Image-Guided
1
2016
39
0.120
 Why?
Surveys and Questionnaires
8
2024
6066
0.120
 Why?
Prostatic Neoplasms
2
2021
978
0.120
 Why?
Neoplasms, Radiation-Induced
1
2016
100
0.120
 Why?
Dyskinesia, Drug-Induced
1
1995
14
0.120
 Why?
Cellular Microenvironment
1
2016
93
0.120
 Why?
Levodopa
1
1995
40
0.110
 Why?
Epithelium
2
2015
310
0.110
 Why?
Antiparkinson Agents
1
1995
41
0.110
 Why?
Cytophagocytosis
1
2015
5
0.110
 Why?
Depression
3
2020
1546
0.110
 Why?
Prophylactic Surgical Procedures
1
2015
7
0.110
 Why?
Adherens Junctions
1
2015
24
0.110
 Why?
Transforming Growth Factor beta3
1
2015
15
0.110
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2018
345
0.110
 Why?
Lung Neoplasms
2
2021
2664
0.110
 Why?
Paracrine Communication
1
2015
67
0.110
 Why?
Phosphoproteins
2
2015
337
0.110
 Why?
Rats
6
2021
5584
0.110
 Why?
Menarche
1
2015
53
0.110
 Why?
Chronic Pain
1
2019
291
0.110
 Why?
Lymphocyte Activation
3
2017
1132
0.110
 Why?
Risk Reduction Behavior
1
2016
217
0.110
 Why?
Lymph Node Excision
2
2021
173
0.110
 Why?
Microfilament Proteins
1
2015
135
0.110
 Why?
Hodgkin Disease
1
2016
171
0.110
 Why?
Spleen
1
2017
508
0.110
 Why?
Pyrimidines
1
2018
530
0.110
 Why?
Survival Analysis
4
2021
1374
0.110
 Why?
Gastrointestinal Microbiome
1
2022
767
0.110
 Why?
Survivors
3
2023
523
0.100
 Why?
Aging
1
2025
1969
0.100
 Why?
Peptide YY
2
2025
28
0.100
 Why?
Amenorrhea
1
2014
31
0.100
 Why?
Extracellular Matrix
2
2016
562
0.100
 Why?
Odds Ratio
4
2020
1082
0.100
 Why?
Mammary Neoplasms, Animal
1
2014
35
0.100
 Why?
Carbon Cycle
1
2014
13
0.100
 Why?
Administration, Oral
3
2025
866
0.100
 Why?
Ghrelin
2
2025
42
0.100
 Why?
Brain Edema
1
2014
62
0.100
 Why?
Calcium-Binding Proteins
1
2015
221
0.100
 Why?
Multivariate Analysis
2
2019
1547
0.100
 Why?
Droughts
1
2014
30
0.100
 Why?
Monocytes
1
2017
539
0.100
 Why?
Collagen
2
2021
457
0.100
 Why?
Disability Evaluation
1
2015
310
0.100
 Why?
Atmosphere
1
2014
52
0.100
 Why?
Spouses
1
2015
108
0.100
 Why?
Tremor
1
1994
98
0.100
 Why?
Astrocytes
1
2015
228
0.100
 Why?
Male
20
2022
72843
0.100
 Why?
Neoplastic Cells, Circulating
2
2016
81
0.100
 Why?
Signal Transduction
4
2020
5216
0.100
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2012
977
0.100
 Why?
Antigens, Differentiation, Myelomonocytic
3
2019
66
0.100
 Why?
Nitriles
1
2014
207
0.090
 Why?
Trans-Activators
1
2015
396
0.090
 Why?
Infertility, Female
1
2014
122
0.090
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2012
27
0.090
 Why?
Lymphatic Vessels
3
2019
63
0.090
 Why?
Triazoles
1
2014
187
0.090
 Why?
Genome-Wide Association Study
1
2019
1407
0.090
 Why?
Postural Balance
1
2015
245
0.090
 Why?
Myeloid Cells
1
2013
147
0.090
 Why?
Apoptosis
3
2019
2440
0.090
 Why?
Drug Design
1
2013
175
0.090
 Why?
Analgesics, Opioid
1
2021
1149
0.090
 Why?
Cardiovascular Diseases
1
2024
2187
0.090
 Why?
Logistic Models
5
2016
2134
0.090
 Why?
Genes, Bacterial
1
2012
152
0.090
 Why?
Live Birth
2
2023
81
0.090
 Why?
Interpersonal Relations
1
2015
397
0.090
 Why?
Wound Healing
1
2014
355
0.090
 Why?
Fibrillar Collagens
1
2011
14
0.090
 Why?
Mice, Inbred C57BL
6
2019
5983
0.090
 Why?
Real-Time Polymerase Chain Reaction
1
2012
337
0.080
 Why?
Double-Blind Method
3
2021
2062
0.080
 Why?
Transcriptome
2
2021
1038
0.080
 Why?
Patient Participation
1
2015
439
0.080
 Why?
Antigen Presentation
2
2018
207
0.080
 Why?
Membrane Proteins
2
2015
1164
0.080
 Why?
B7-H1 Antigen
2
2026
244
0.080
 Why?
Biopsy, Needle
1
2011
185
0.080
 Why?
Streptococcus agalactiae
1
2012
110
0.080
 Why?
Xenograft Model Antitumor Assays
3
2020
934
0.080
 Why?
Estrogen Antagonists
1
2010
37
0.080
 Why?
Adenocarcinoma
2
2015
925
0.080
 Why?
Sexual Behavior
1
2014
494
0.080
 Why?
Cell Fusion
2
2006
48
0.080
 Why?
Pregnancy Trimester, Second
1
2009
83
0.070
 Why?
Radiotherapy, Adjuvant
2
2021
222
0.070
 Why?
Clinical Trials as Topic
3
2017
1061
0.070
 Why?
Sentinel Lymph Node Biopsy
3
2021
117
0.070
 Why?
Mucin-1
1
2009
21
0.070
 Why?
Reference Standards
2
2012
177
0.070
 Why?
Cell Movement
3
2019
959
0.070
 Why?
In Situ Hybridization, Fluorescence
3
2019
325
0.070
 Why?
Interferon beta-1a
1
2008
14
0.070
 Why?
Glatiramer Acetate
1
2008
18
0.070
 Why?
Pregnancy Trimester, First
1
2009
139
0.070
 Why?
Macrophage Activation
1
2010
181
0.070
 Why?
Clinical Trials, Phase I as Topic
2
2020
50
0.070
 Why?
Apoptosis Regulatory Proteins
1
2009
187
0.070
 Why?
Rats, Sprague-Dawley
4
2016
2524
0.070
 Why?
Dose-Response Relationship, Drug
3
2018
2028
0.070
 Why?
Interferon-beta
1
2008
92
0.070
 Why?
Metalloproteases
1
2008
42
0.070
 Why?
Extracellular Matrix Proteins
1
2009
156
0.070
 Why?
Sensitivity and Specificity
3
2013
1997
0.070
 Why?
Gonadal Steroid Hormones
1
2009
143
0.070
 Why?
Phenotype
3
2026
3155
0.070
 Why?
Age of Onset
2
2021
555
0.070
 Why?
Intercellular Signaling Peptides and Proteins
1
2009
376
0.060
 Why?
Cell Cycle
2
2021
598
0.060
 Why?
Genomics
2
2023
825
0.060
 Why?
Disease Susceptibility
1
2009
344
0.060
 Why?
Maximum Tolerated Dose
2
2018
210
0.060
 Why?
ErbB Receptors
3
2017
635
0.060
 Why?
Gene Knockdown Techniques
2
2020
333
0.060
 Why?
Mice, Nude
3
2015
679
0.060
 Why?
Sternum
1
2006
27
0.060
 Why?
Antibodies, Monoclonal
3
2009
1505
0.060
 Why?
Cell Survival
2
2020
1100
0.060
 Why?
Cells, Cultured
3
2019
4148
0.060
 Why?
Polymerase Chain Reaction
2
2016
1041
0.060
 Why?
Membrane Glycoproteins
2
2019
499
0.060
 Why?
Ovariectomy
2
2019
166
0.060
 Why?
Risk Assessment
3
2026
3747
0.060
 Why?
HIV Infections
1
2001
3194
0.060
 Why?
Postmenopause
2
2005
392
0.060
 Why?
Axilla
2
2021
51
0.060
 Why?
Keratins
1
2026
171
0.060
 Why?
Child
6
2022
22707
0.060
 Why?
Models, Biological
2
2012
1764
0.060
 Why?
Forkhead Transcription Factors
2
2018
207
0.060
 Why?
Prolactin
1
2025
87
0.060
 Why?
Mammaplasty
2
2021
142
0.060
 Why?
Fear
2
2021
368
0.060
 Why?
Anti-Mullerian Hormone
1
2025
61
0.050
 Why?
Mice, Knockout
2
2025
3124
0.050
 Why?
Thyrotropin
1
2025
120
0.050
 Why?
Infant, Newborn
2
2023
6447
0.050
 Why?
PTEN Phosphohydrolase
1
2026
165
0.050
 Why?
Dendritic Cells
2
2005
499
0.050
 Why?
Enzyme Inhibitors
1
2008
820
0.050
 Why?
Analysis of Variance
3
2014
1300
0.050
 Why?
Solubility
1
2005
240
0.050
 Why?
Congresses as Topic
1
2026
223
0.050
 Why?
Neoplastic Processes
1
2023
5
0.050
 Why?
Ovulation Induction
1
2024
65
0.050
 Why?
Cancer Vaccines
1
2005
161
0.050
 Why?
Follicle Stimulating Hormone
1
2025
266
0.050
 Why?
Weaning
2
2016
51
0.050
 Why?
Epithelial-Mesenchymal Transition
1
2025
219
0.050
 Why?
North America
1
2024
302
0.050
 Why?
Cryopreservation
1
2024
113
0.050
 Why?
Celecoxib
2
2014
42
0.050
 Why?
Sensation
1
2022
55
0.050
 Why?
Withholding Treatment
1
2023
80
0.050
 Why?
DNA End-Joining Repair
1
2022
22
0.050
 Why?
Peptides
1
2008
998
0.050
 Why?
Mucins
1
2022
75
0.040
 Why?
Cost of Illness
1
2024
324
0.040
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2023
334
0.040
 Why?
Chromosome Aberrations
1
2022
166
0.040
 Why?
Colorado
3
2020
4554
0.040
 Why?
Psychiatric Status Rating Scales
2
2015
531
0.040
 Why?
Chemoradiotherapy, Adjuvant
1
2021
44
0.040
 Why?
Evidence-Based Medicine
1
2025
740
0.040
 Why?
Genes, p53
1
2021
67
0.040
 Why?
Multiple Myeloma
1
2005
309
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2021
116
0.040
 Why?
Placebos
1
2021
193
0.040
 Why?
Hypertrophy
1
2021
128
0.040
 Why?
Reproducibility of Results
2
2012
3413
0.040
 Why?
In Situ Hybridization
1
2001
318
0.040
 Why?
Protective Agents
1
2021
42
0.040
 Why?
Societies, Medical
1
2025
899
0.040
 Why?
Referral and Consultation
1
2007
867
0.040
 Why?
Immunity
1
2021
140
0.040
 Why?
Neoplasm, Residual
1
2021
143
0.040
 Why?
Hormones
1
2021
135
0.040
 Why?
DNA Replication
1
2022
249
0.040
 Why?
Hospitals, University
1
2021
176
0.040
 Why?
Early Detection of Cancer
1
2026
485
0.040
 Why?
CD4-Positive T-Lymphocytes
2
2019
1140
0.040
 Why?
Arm
1
2021
110
0.040
 Why?
Pregnancy Rate
1
2020
81
0.040
 Why?
Cross-Over Studies
1
2022
608
0.040
 Why?
Flow Cytometry
3
2013
1162
0.040
 Why?
DNA Repair
1
2022
254
0.040
 Why?
Morbidity
1
2021
322
0.040
 Why?
Consolidation Chemotherapy
1
2019
11
0.040
 Why?
Confidence Intervals
1
2020
330
0.040
 Why?
Multicenter Studies as Topic
1
2021
412
0.040
 Why?
Kidney Neoplasms
1
2004
413
0.040
 Why?
Age Distribution
1
2020
403
0.040
 Why?
SEER Program
1
2021
229
0.040
 Why?
Patient Reported Outcome Measures
1
2024
497
0.040
 Why?
DNA, Viral
1
2001
356
0.040
 Why?
Base Sequence
2
2016
2170
0.040
 Why?
Vaginal Diseases
1
2019
19
0.040
 Why?
Fibronectins
1
2020
136
0.040
 Why?
Unemployment
1
2019
43
0.040
 Why?
Severity of Illness Index
2
2019
2930
0.040
 Why?
Leuprolide
1
2019
21
0.040
 Why?
Terminology as Topic
1
2021
257
0.040
 Why?
Mammary Neoplasms, Experimental
1
2019
62
0.040
 Why?
Sulfonamides
2
2014
583
0.040
 Why?
Interleukin-10
2
2014
309
0.040
 Why?
Crosses, Genetic
1
2018
123
0.030
 Why?
Hot Flashes
1
2019
91
0.030
 Why?
Weight Gain
1
2022
561
0.030
 Why?
Maintenance Chemotherapy
1
2018
42
0.030
 Why?
Factor Analysis, Statistical
1
2019
291
0.030
 Why?
Integrins
1
2018
90
0.030
 Why?
Body Weight
1
2022
971
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2019
167
0.030
 Why?
Kynurenine
1
2018
114
0.030
 Why?
Antimetabolites, Antineoplastic
1
2018
106
0.030
 Why?
Contraceptives, Oral
1
2017
37
0.030
 Why?
RNA, Small Interfering
1
2020
637
0.030
 Why?
Behavior
1
2018
89
0.030
 Why?
Patient Satisfaction
1
2021
709
0.030
 Why?
Dietary Supplements
1
2021
583
0.030
 Why?
Educational Status
1
2019
466
0.030
 Why?
Tumor Escape
1
2017
49
0.030
 Why?
Weight Loss
1
2022
858
0.030
 Why?
Drug Therapy, Combination
1
2019
1044
0.030
 Why?
National Cancer Institute (U.S.)
1
2016
54
0.030
 Why?
Cell Count
1
2017
319
0.030
 Why?
Emulsions
1
2016
59
0.030
 Why?
Alleles
1
2019
894
0.030
 Why?
Stress Disorders, Post-Traumatic
1
2024
890
0.030
 Why?
Immune Tolerance
1
2018
385
0.030
 Why?
Radiotherapy Dosage
1
2016
288
0.030
 Why?
Population Surveillance
1
2019
484
0.030
 Why?
Immunophenotyping
1
2017
319
0.030
 Why?
Antigens, Differentiation
1
2015
76
0.030
 Why?
Radiotherapy Planning, Computer-Assisted
1
2016
149
0.030
 Why?
Body Mass Index
2
2015
2445
0.030
 Why?
Directive Counseling
1
2015
45
0.030
 Why?
Hybrid Cells
2
2005
49
0.030
 Why?
Molecular Targeted Therapy
1
2018
439
0.030
 Why?
Reproduction
1
2016
208
0.030
 Why?
Biomarkers
2
2021
4295
0.030
 Why?
Randomized Controlled Trials as Topic
1
2021
1747
0.030
 Why?
Amyloid Precursor Protein Secretases
1
2015
78
0.030
 Why?
Medicare
1
2021
903
0.030
 Why?
Medication Adherence
1
2019
540
0.030
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
261
0.030
 Why?
Posture
1
2015
197
0.030
 Why?
Tropical Climate
1
2014
15
0.030
 Why?
Genotype
1
2019
1852
0.030
 Why?
Cognition
1
2022
1266
0.030
 Why?
Biota
1
2014
29
0.030
 Why?
Leukocyte Common Antigens
1
2014
87
0.030
 Why?
Dinoprostone
1
2014
180
0.030
 Why?
Trees
1
2014
59
0.030
 Why?
Fresh Water
1
2014
53
0.030
 Why?
STAT5 Transcription Factor
1
2013
50
0.030
 Why?
Tumor Burden
1
2015
325
0.030
 Why?
Terminal Care
1
2018
283
0.030
 Why?
Rain
1
2014
39
0.020
 Why?
Biomass
1
2014
96
0.020
 Why?
Blood Cell Count
1
2013
55
0.020
 Why?
Carbon Monoxide
1
2014
82
0.020
 Why?
Brazil
1
2014
179
0.020
 Why?
Dermoscopy
1
2013
11
0.020
 Why?
Immunoblotting
1
2014
295
0.020
 Why?
Clinical Decision-Making
1
2017
363
0.020
 Why?
Massachusetts
1
2014
180
0.020
 Why?
Necrosis
1
2014
244
0.020
 Why?
Family Health
1
1994
191
0.020
 Why?
Oncogenes
1
2013
118
0.020
 Why?
Wnt Signaling Pathway
1
2015
211
0.020
 Why?
Photosynthesis
1
2014
99
0.020
 Why?
Lipopolysaccharide Receptors
1
2013
88
0.020
 Why?
Fires
1
2014
77
0.020
 Why?
beta Catenin
1
2015
254
0.020
 Why?
Child, Preschool
2
2021
11853
0.020
 Why?
Karyotyping
1
2012
105
0.020
 Why?
Magnetic Resonance Imaging
1
2025
3904
0.020
 Why?
Immune System
1
2014
180
0.020
 Why?
Adiposity
1
2017
532
0.020
 Why?
Gonadotropin-Releasing Hormone
1
2014
217
0.020
 Why?
Accidental Falls
1
2015
226
0.020
 Why?
Opioid-Related Disorders
1
2021
602
0.020
 Why?
Observer Variation
1
2013
357
0.020
 Why?
Endothelial Cells
1
2018
874
0.020
 Why?
Carbon Dioxide
1
2014
227
0.020
 Why?
Cell Division
1
2013
756
0.020
 Why?
Comorbidity
1
2017
1661
0.020
 Why?
Menopause
1
2015
326
0.020
 Why?
Carcinogenesis
1
2013
228
0.020
 Why?
Calibration
1
2012
152
0.020
 Why?
Recurrence
1
2015
1138
0.020
 Why?
Polymorphism, Single Nucleotide
1
2019
2158
0.020
 Why?
Interferon-gamma
2
2005
784
0.020
 Why?
Seasons
1
2014
538
0.020
 Why?
RNA, Bacterial
1
2012
182
0.020
 Why?
Tomography, X-Ray Computed
2
2015
2769
0.020
 Why?
Cell Line
1
2016
2823
0.020
 Why?
Cell Differentiation
1
2018
2046
0.020
 Why?
Genome, Human
1
2013
420
0.020
 Why?
Mice, SCID
1
2011
369
0.020
 Why?
Photochemotherapy
1
2010
39
0.020
 Why?
Self Report
1
2015
870
0.020
 Why?
Universities
1
2013
445
0.020
 Why?
Gene Expression Regulation, Bacterial
1
2012
337
0.020
 Why?
Feasibility Studies
1
2014
1111
0.020
 Why?
Microscopy, Confocal
1
2010
319
0.020
 Why?
Hypertension
1
2018
1273
0.020
 Why?
Matrix Metalloproteinases
1
2010
95
0.020
 Why?
Survival Rate
1
2014
2090
0.020
 Why?
Keratin-19
1
2009
4
0.020
 Why?
Immunomagnetic Separation
1
2009
4
0.020
 Why?
Palliative Care
1
2018
1020
0.020
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2009
21
0.020
 Why?
Dose-Response Relationship, Immunologic
1
2009
76
0.020
 Why?
Diagnosis, Differential
1
2013
1508
0.020
 Why?
Blotting, Western
1
2011
1179
0.020
 Why?
Physician-Patient Relations
1
2014
588
0.020
 Why?
Vinblastine
1
2009
75
0.020
 Why?
Species Specificity
1
2010
546
0.020
 Why?
ADAM12 Protein
1
2008
4
0.020
 Why?
Flavonoids
1
2009
85
0.020
 Why?
Estrogen Receptor Modulators
1
2008
14
0.020
 Why?
Perilipin-1
1
2008
16
0.020
 Why?
S100 Proteins
1
2008
35
0.020
 Why?
Sex Factors
1
1994
2105
0.020
 Why?
ADAM Proteins
1
2008
64
0.020
 Why?
Androstadienes
1
2008
75
0.020
 Why?
Perimenopause
1
2008
69
0.020
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2009
133
0.020
 Why?
DNA Primers
1
2009
505
0.020
 Why?
Matrix Metalloproteinase 9
1
2008
131
0.020
 Why?
Radiotherapy
1
2008
204
0.020
 Why?
Prevalence
1
2014
2865
0.020
 Why?
Gene Expression
1
2012
1476
0.020
 Why?
Piperidines
1
2009
222
0.020
 Why?
Chi-Square Distribution
1
2008
527
0.020
 Why?
Cluster Analysis
1
2008
500
0.020
 Why?
Precancerous Conditions
1
2008
166
0.020
 Why?
Protein Structure, Tertiary
1
2009
855
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2008
749
0.010
 Why?
Pleural Effusion
1
2006
59
0.010
 Why?
Lymphocyte Culture Test, Mixed
1
2005
49
0.010
 Why?
Cytotoxicity Tests, Immunologic
1
2005
39
0.010
 Why?
Receptors, CCR7
1
2005
32
0.010
 Why?
Receptors, Chemokine
1
2005
48
0.010
 Why?
Antigens, CD34
1
2005
89
0.010
 Why?
Interleukin-12
1
2005
115
0.010
 Why?
Hemocyanins
1
2004
61
0.010
 Why?
Positron-Emission Tomography
1
2006
343
0.010
 Why?
Carrier Proteins
1
2008
728
0.010
 Why?
Coculture Techniques
1
2004
247
0.010
 Why?
Patient Care Planning
1
2005
170
0.010
 Why?
Cell Separation
1
2004
305
0.010
 Why?
Cell Nucleus
1
2006
588
0.010
 Why?
Tumor Cells, Cultured
1
2004
886
0.010
 Why?
Brain
1
2014
2947
0.010
 Why?
Paclitaxel
1
2003
257
0.010
 Why?
Pilot Projects
1
2003
1891
0.010
 Why?
Vaccination
1
2004
1426
0.010
 Why?
Borges's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (593) concept(s)
_
Co-Authors Expand Description
See all (68) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)